A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor Microenvironment.

Autor: Jeon, Yeejin1 (AUTHOR) yjeon@qurient.com, Kang, Hwankyu1 (AUTHOR), Yang, Yeongin1 (AUTHOR), Park, Dongsik1 (AUTHOR), Choi, Baejung1 (AUTHOR), Kim, Jeongjun1 (AUTHOR), Kim, Jaeseung1 (AUTHOR), Nam, Kiyean1 (AUTHOR)
Zdroj: Cancers. Oct2022, Vol. 14 Issue 19, p4821. 20p.
Databáze: Academic Search Ultimate